ArticleCancer letters2022

Enzalutamide-induced and PTH1R-mediated TGFBR2 degradation in osteoblasts confers resistance in prostate cancer bone metastases.

Shang Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.